What happened
LigaChem Biosciences updated the terms of convertible bonds to raise US$224M, about 10.7% of its market value.
For context, this raise equals about 10.7% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$224M |
| vs. market value | 10.7% |
| Filed | 2026-07-22, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260722000071 → open original filing |
Source: DART. Information only, not investment advice.